Xcout Intel
En Carta Diagnostics competitors & alternatives
The 12 closest competitors and alternatives to En Carta Diagnostics among diagnostic equipment companies — ranked by similarity to what En Carta Diagnostics actually does, not by market-cap band.
Subscribe to see En Carta Diagnostics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About En Carta Diagnostics
En Carta Diagnostics develops diagnostic products, including an FDA Breakthrough-designated Lyme disease test, to provide rapid and accurate medical testing for patients and healthcare providers.
En Carta Diagnostics at a glance
En Carta Diagnostics is a diagnostic equipment company headquartered in France. It has raised at least $7M across the 2 funding rounds on record. Its most recent funding round, Seed, raised $5.5M in July 2026. Xcout tracks 5 named people at En Carta Diagnostics, including Guillaume Horreard (President).
En Carta Diagnostics leadership
- Guillaume HorreardPresident
- Margot KarlikowCTO & Co-founder
- Marc JulienCBDSO
- Alexander GreenStrategic Advisor & Co-founder
- Keith PardeeStrategic Advisor & Co-founder
En Carta Diagnostics funding rounds
At least $7M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $5.5M | 5 named | |
| Pre-Seed | $1.5M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 En Carta Diagnostics competitors
Ranked by semantic similarity — how close each company is to En Carta Diagnostics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Medical Devices & Healthcare
Pictura Bio is a medical technology company developing a one-minute pathogen detection platform utilizing proprietary hardware and computer vision for infectious disease diagnostics. Its point-of-care system, which includes the PIC-ID and VISTA reader technologies, provides rapid identification and differentiation of pathogens to assist frontline healthcare providers.
Medical Devices
Prolight Diagnostics develops innovative point-of-care in-vitro diagnostic systems that utilize proprietary digital technology to perform blood tests and deliver reliable results within minutes. The company serves healthcare providers by enabling rapid biomarker detection and decentralized testing outside of traditional hospital laboratories.
Medical Devices & Diagnostics
Abbott Point of Care provides rapid diagnostic testing solutions and point-of-care medical devices for healthcare professionals.
Biotechnology and Medical Devices
SD Biosensor is a global diagnostic reagents company that develops and supplies a wide range of diagnostic testing platforms and products, including rapid tests, molecular diagnostics, fluorescence immunoassays, and blood glucose meters. The company serves healthcare providers, laboratories, and patients by offering screening and confirmatory testing solutions for infectious diseases, chronic conditions, and other health markers.
Biotech
Biofire Group develops syndromic infectious disease diagnostics systems and multiplex PCR testing panels. The company serves clinical laboratories and healthcare providers by delivering rapid detection results for pathogens such as viruses, bacteria, and resistance genes.
Medical Devices
MedMira Inc. is a biotechnology company focused on the research, development, manufacturing, and global commercialization of rapid diagnostic solutions and related technology platforms. Its operations span North America, Europe, the Asia Pacific region, and other international markets. MedMira offers a diverse portfolio of rapid diagnostic tests and technology platforms. Its diagnostic solutions include Reveal HIV, which identifies HIV-1 and HIV-2 antibodies in various blood samples; Reveal TP, a rapid test for syphilis antibodies (Treponema pallidum); and Reveal HP, designed to detect Helicobacter pylori antibodies. The company also provides Multiplo, a line of multiplex tests for combined screening of conditions such as HIV-1/2, Hepatitis B and C, and syphilis, as well as the Miriad triple product for initial HIV and hepatitis screening. In the realm of respiratory and viral diagnostics, MedMira developed VYRA CoV2 for SARS-CoV-2 nucleocapsid antigen detection, VYRA CoV2Flu for simultaneous antigen testing of SARS-CoV-2, Influenza A, and Influenza B, and REVEALCOVID-19, an antibody test for COVID-19. Beyond diagnostic kits, MedMira provides the Miriad RVF toolkit, a platform that facilitates the development and market entry of rapid diagnostics. MedMira distributes its offerings through a wide network of medical distributors and strategic partners. Its customer base is broad, serving various segments of the healthcare industry, including clinical laboratories, hospitals, point-of-care clinics, government agencies, humanitarian aid groups, and public health bodies. The company was established in 1993, is headquartered in Halifax, Canada, and operates as a subsidiary of MedMira Holding AG.
Similar diagnostic equipment company
Embio Diagnostics is a biotechnology company headquartered in Nicosia, Cyprus, that designs and develops portable, biosensor-based digital devices for rapid testing across various global industries.
Medical Devices
NanoSynex is a medical technology company that develops rapid diagnostic systems to test for antibiotic resistance and provide personalized antibiotic treatments. The company serves the healthcare sector by aiming to speed up bacterial diagnosis, improve testing quality, and combat the antibiotics crisis.
Medical Device
EnteroTrack, LLC provides the Esophageal String Test (EST) using its EnteroTracker device, offering a minimally invasive, non-endoscopic tool for clinicians to collect upper gastrointestinal samples and monitor Eosinophilic Esophagitis (EoE) activity in patients. The office-based procedure helps assess mucosal inflammation and biomarkers over time, potentially reducing the need for repeated endoscopies.
Medical Devices, Diagnostics, Life Sciences
Beckman Coulter Diagnostics provides clinical diagnostic products, laboratory automation systems, and testing solutions across disciplines such as chemistry, immunoassay, hematology, and microbiology. The company serves healthcare providers and laboratories by delivering accurate and timely diagnostic insights to inform clinical decisions and improve patient care.
Biotechnology, Medical Devices, Diagnostics
Spartan Bioscience was a Canadian biotechnology and diagnostics company based in Ottawa that developed portable, rapid PCR-based DNA analyzers and associated test kits. Its products were intended for healthcare providers, laboratories, and other organizations needing decentralized testing for infectious diseases and genetic targets, including COVID-19.
Medical Devices, Biotech
NanoEntek Inc. develops and manufactures life science research solutions and in-vitro diagnostic (IVD) medical devices utilizing lab-on-a-chip technology based on MEMS and micro-fluidics. The company provides products such as automated cell counters, electroporation systems, live cell imaging devices, and microfluidic immunofluorescence analyzers to support laboratories and medical professionals.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of En Carta Diagnostics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for En Carta Diagnosticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →